PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Moreover, increased hepatic fat content is associated with ceramide-rich liver lipids in “metabolic NAFLD”, but not in “pathatin-like phospholipase containing (PNPLA3) NAFLD” [93].